STEREOTAXIS INC
STXSNYSE AMERICANTrading Snapshot
- Day Range
- $1.24 β $1.27
- 52-Week Range
- $1.24 β $3.59
- Volume
- $4.00B
- Avg Volume
- $3.61B
- Shares Outstanding
- 97.9M
- Next Earnings
- Nov 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $32M
- Last Q Revenue
- $8M
- P/E Ratio
- -5.3
- P/S Ratio
- 4.2x
- EPS (TTM)
- $-0.22
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +10.5%
Why Investors Own STXS
- βHigh-growth profile β revenue up +3.5% YoY with expanding US Equity exposure.
- βHealthy economics β 78% gross margin and 22% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
STEREOTAXIS INC
STXSAbout STEREOTAXIS INC
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
STEREOTAXIS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift STXS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
STEREOTAXIS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.